Prednipharm

to the catalogue

Prednisolone, developed specifically for veterinary clinics. An injectable solution with a convenient dosage for safe use in cats and dogs

Legal use in clinics
Optimal concentration, providing easy and accurate dosing
Dosage form adapted for cats and dogs
Convenient for repeated use of vials

Composition

Pharmacological properties

Indications

Dosage and method of administration

Restrictions

1 ml Prednipharm

prednisolone 10 mg

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.

Pharmacological properties

Prednipharm belongs to the group of glucocorticosteroids. It provides anti-inflammatory, antiallergic, immunosuppressive, antipruritic, and antiexudative effects, increases the sensitivity of beta-adrenergic receptors to candogenic catecholamines.

Indications

Prednipharm is used in cats and dogs, including for emergency therapy in conditions requiring a rapid increase in the concentration of GCs in the body, initial therapy and short-term symptomatic treatment:

skin diseases of various origins (including eczema, atopic dermatitis, taxidermy, pyoderma and other dermatitis caused by parasitic invasions and bacterial infections, as well as leafy pemphigus, systemic red (discoid) lupus and other autoimmune skin pathologies)
inflammatory processes of various origins (including arthritis, arthrosis, synovitis, bursitis, herniated discs and other inflammatory processes of the articular apparatus)
systemic diseases of connective tissue, including rheumatism
in acute infectious diseases (combination with antimicrobial agents)
bronchial asthma, asthmatic status of the animal
allergic reactions (acute severe forms), anaphylactic shock, anaphylactic reactions, serum sickness
autoimmune hemolytic anemia, aplastic anemia, thrombocytopenia, adrenal insufficiency, progressive ophthalmopathy
stressful conditions (exhibitions, training)
shock conditions (burn, traumatic, surgical, toxic, cardiogenic), with the ineffectiveness of vasoconstrictors, plasma replacement drugs and other symptomatic therapy
some oncological diseases (leukemia, lymphoma, mastocytoma, etc.)

Dosage and method of administration

Indicator	Cats and dogs
	Dosage
As an anti-inflammatory and adaptogenic agent	0.03-0.05 ml per 1 kg of animal body weight (corresponds to 0.25-0.5 mg of prednisone per 1 kg of animal body weight)
For immunoregulation (incl. to relieve sensitization, itching, shock conditions)	0.05-0.2 ml per 1 kg of animal body weight (corresponds to 0.5-2 mg of prednisone per 1 kg of animal body weight)
For oncological diseases (as a cytostatic agent)	0.2-0.4 ml per 1 kg of animal body weight (corresponds to 2-4 mg of prednisone per 1 kg of animal body weight)
As part of antishock therapy	0.1-1 ml per 1 kg of animal body weight (corresponds to 1-10 mg of prednisone per 1 kg of animal body weight)

The dose of the veterinary drug, the frequency and duration of the course of treatment are set by a veterinarian individually, depending on the indications, the severity of the disease and the condition of the animal.

Restrictions

Contraindications and special instructions:
Heart failure.
Renal failure.
Peptic ulcer of the stomach and duodenum.
Hypercorticism (Cushing's syndrome).
Diabetes mellitus.
Osteoporosis.
Hypersensitivity to prednisone or the components of the veterinary drug.
Predisposition to thromboembolism, severe arterial hypertension, ascites, viral diseases.
During the vaccination period (immediately before and during vaccination).
Simultaneous use of Prednipharm with diuretics, NSAID group drugs, anticoagulants and thrombolytics, vitamin D, praziquantel, live antiviral vaccines is not recommended.
Barbiturates, phenytoin and rifampicin reduce the glucocorticoid activity of prednisone.

Prednipharm

Similar products